Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Epratuzumab/rituximab combination active in recurrent non-Hodgkin's lymphoma

Dec. 21, 2007

Dock-and-lock-generated dimeric interferon shows potential in cancer therapy

Dec. 21, 2007

Anti-CD22 agent plus chemotherapy yields positive preclinical results in pre-B ALL

Dec. 21, 2007

Pooled data show efficacy of desvenlafaxine in depression across ages, genders

Dec. 21, 2007

Single-agent activity seen with perifosine in malignant gliomas

Dec. 21, 2007

Omega-3 fatty acids may prevent development of psychosis in at-risk adolescents

Dec. 21, 2007

Improved pharmacokinetic profile of novel recombinant FVII fusion protein

Dec. 20, 2007

Anti-KIR monoclonal antibody enhances NK cell killing activity in vitro and in vivo

Dec. 20, 2007

Cognition improved in schizophrenic patients given rivastigmine

Dec. 20, 2007

Studies show benefit with quetiapine in bipolar and borderline personality disorders

Dec. 20, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...